Nuvation Bio Inc. NUVB
$5.00
+1.01%
at last close
Analyst Consensus
- Consensus Rating
- Buy (9 Buy · 1 Hold · 0 Sell)
- Average Price Target
- $13.22
- Implied Upside
- +164.4%
- Price Target Range
- $7.00 – $21.00
- Analysts (12 mo)
- 10
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-09-30 | CitigroupGeoff Meacham |
Initiates coverage on | Buy | $12 |
| 2026-09-16 | CitizensSilvan Turkcan |
Reiterates | Market outperform | $10 |
| 2026-09-16 | WedbushDavid Nierengarten |
Reiterates | Outperform | $11 |
| 2026-08-21 | Cantor FitzgeraldLi Watsek |
Initiates coverage on | Overweight | — |
| 2026-08-18 | JP MorganPriyanka Grover |
Initiates coverage on | Overweight | $13 |
| 2026-08-07 | RBC CapitalLeonid Timashev |
Maintains | Outperform | $19 → $20 |
| 2026-07-27 | HC Wainwright & Co.Robert Burns |
Maintains | Buy | $17 → $21 |
| 2026-07-23 | WedbushDavid Nierengarten |
Reiterates | Outperform | $11 |
| 2026-07-07 | RBC CapitalLeonid Timashev |
Maintains | Outperform | $20 → $19 |
| 2026-07-07 | Truist SecuritiesGregory Renza |
Maintains | Buy | $12 → $13 |
| 2026-05-05 | RBC CapitalLeonid Timashev |
Reiterates | Outperform | $20 |
| 2026-05-05 | WedbushDavid Nierengarten |
Reiterates | Outperform | $11 |
| 2026-05-05 | HC Wainwright & Co.Robert Burns |
Reiterates | Buy | $17 |
| 2026-04-16 | WedbushDavid Nierengarten |
Reiterates | Outperform | $11 |
| 2026-04-02 | WedbushDavid Nierengarten |
Reiterates | Outperform | $11 |
| 2026-03-27 | WedbushDavid Nierengarten |
Reiterates | Outperform | $11 |
| 2026-03-03 | UBSMichael Yee |
Maintains | Neutral | $10 → $7 |
| 2026-03-03 | RBC CapitalLeonid Timashev |
Maintains | Outperform | $12 → $13 |
| 2026-02-10 | WedbushDavid Nierengarten |
Reiterates | Outperform | $11 |
| 2026-01-21 | RBC CapitalLeonid Timashev |
Maintains | Outperform | $9 → $12 |
| 2026-01-12 | HC Wainwright & Co.Robert Burns |
Maintains | Buy | $18 → $17 |
| 2026-01-07 | UBSMichael Yee |
Initiates coverage on | Neutral | $10 |
| 2025-12-11 | HC Wainwright & Co.Robert Burns |
Maintains | Buy | $10 → $18 |
| 2025-12-01 | HC Wainwright & Co.Robert Burns |
Reiterates | Buy | $10 |
| 2025-11-24 | Truist SecuritiesGregory Renza |
Initiates coverage on | Buy | $11 |
| 2025-11-20 | CitizensSilvan Tuerkcan |
Maintains | Market outperform | $8 → $10 |
| 2025-11-19 | B. Riley SecuritiesMayank Mamtani |
Initiates coverage on | Buy | $12 |
| 2025-11-04 | RBC CapitalLeonid Timashev |
Maintains | Outperform | $7 → $8 |
| 2025-11-04 | CitizensSilvan Tuerkcan |
Maintains | Market outperform | $6 → $8 |
| 2025-10-13 | WedbushDavid Nierengarten |
Reiterates | Outperform | $6 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $5.00
- Market Cap
- $1.76 billion
- 52-Week Range
- $2.99 – $9.75
- Average Volume
- 5.32 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.